TEAMtalk.com on MSN
Deal agreed – Star whose contract was terminated by Arsenal joins European royalty
Former Arsenal defender Takehiro Tomiyasu - who left via mutual consent over the summer - has verbally agreed a six-month ...
Asian shipping tycoon Chavalit Frederick Tsao’s investment vehicle, Octave Capital, has teamed up with Norwegian impact ...
The legacy of Indian royalty lives on through seven princely families — Mewar, Gwalior, Baroda, Mysore, Jaipur, Bikaner and ...
India is preparing to rewrite the rules for how artificial intelligence companies can use locally created content. This is a ...
Royalty Pharma plc (Nasdaq: RPRX) and Denali Therapeutics, Inc. (Nasdaq: DNLI) today announced a $275 million synthetic royalty funding agreement based on future net sales of tividenofusp alfa.
In return, Royalty will receive a 9.25% royalty on worldwide sales of tividenofusp alfa from Denali until it reaches three times the amount Royalty has handed to Denali—or, alternatively, 2.5 times ...
TEAMtalk on MSN
Ruben Amorim, Man Utd at odds over star’s exit amid interest from European royalty – sources
A host of clubs are targeting the 24-year-old in the run up to January, though his exit would anger United boss Ruben Amorim ...
The panel’s report recommends a "hybrid model" that guarantees AI companies access to data while ensuring creators get paid.
Bernardo Silva seemed to have given City a comfortable cushion when he lashed the ball beyond Thibaut Courtois from range.
German football is largely immune to foreign ownership. The 50+1 rule prevents the majority of clubs from being controlled by anyone other than members, while more general hostility to private equity ...
Investing.com -- Denali Therapeutics Inc (NASDAQ:DNLI) stock rose 5.7% on Thursday after the company announced a $275 million synthetic royalty funding agreement with Royalty Pharma plc (NASDAQ:RPRX) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback